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Abstract
Background: New systems biology studies require researchers to understand how interplay
among myriads of biomolecular entities is orchestrated in order to achieve high-level cellular and
physiological functions. Many software tools have been developed in the past decade to help
researchers visually navigate large networks of biomolecular interactions with built-in template-
based query capabilities. To further advance researchers' ability to interrogate global physiological
states of cells through multi-scale visual network explorations, new visualization software tools still
need to be developed to empower the analysis. A robust visual data analysis platform driven by
database management systems to perform bi-directional data processing-to-visualizations with
declarative querying capabilities is needed.
Results: We developed ProteoLens as a JAVA-based visual analytic software tool for creating,
annotating and exploring multi-scale biological networks. It supports direct database connectivity
to either Oracle or PostgreSQL database tables/views, on which SQL statements using both Data
Definition Languages (DDL) and Data Manipulation languages (DML) may be specified. The robust
query languages embedded directly within the visualization software help users to bring their
network data into a visualization context for annotation and exploration. ProteoLens supports
graph/network represented data in standard Graph Modeling Language (GML) formats, and this
enables interoperation with a wide range of other visual layout tools. The architectural design of
ProteoLens enables the de-coupling of complex network data visualization tasks into two distinct
phases: 1) creating network data association rules, which are mapping rules between network node
IDs or edge IDs and data attributes such as functional annotations, expression levels, scores,
synonyms, descriptions etc; 2) applying network data association rules to build the network and
perform the visual annotation of graph nodes and edges according to associated data values. We
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demonstrated the advantages of these new capabilities through three biological network
visualization case studies: human disease association network, drug-target interaction network and
protein-peptide mapping network.
Conclusion: The architectural design of ProteoLens makes it suitable for bioinformatics expert
data analysts who are experienced with relational database management to perform large-scale
integrated network visual explorations. ProteoLens is a promising visual analytic platform that will
facilitate knowledge discoveries in future network and systems biology studies.
Background
The concept of networks is ubiquitous in systems biology.
In the past decade, high-throughput experimental tech-
niques such as yeast 2-hybrid systems and mass spectrom-
etry-based proteomics led to an influx of biomolecular
interaction data in curated databases such as HPRD [1],
DIP [2], and BIND [3]. Computational methods to predict
protein interactions with domain interaction profiles [4],
co-expression patterns [5], and term co-occurrences based
on text mining [6] have also led to the development of
databases such as OPHID [7], InterNetDB [8], UniHi [9],
HAPPI [10], and STRING [11]. These databases support
the transformation of biological network studies into
essential biological data analysis tasks that include infer-
ring global protein functions [12], assembling protein
modules [13], integrating different Omics data sets [14],
reconstructing biological pathways [15], predicting dis-
ease-relevant genes/proteins [16] and developing panel
biomarkers [17].
Many network visualization software tools have been
developed recently to help biological researchers visually
query, annotate and analyze biomolecular network data.
For example, Cytoscape [18] is one of the most commonly
used software platforms that contains all basic functions
for visualizing and annotating a network graph derived
from protein-protein or protein-DNA interaction data. It
has a robust graph layout engine that allows for automatic
layout and manual control of network graph nodes and
edges attributes corresponding to user annotation data.
Cytoscape adopts an open and flexible software architec-
ture that supports software plug-ins, which extends the
core functionality of Cytoscape through third-party soft-
ware extensions. VisANT [19] competes with Cytoscape by
offering several built-in statistical functions to help users
calculate several key network topological parameters and
perform global real-time network analysis. WebInter-
Viewer [20] uses a ultra-fast graph-layout algorithm that
can scale up for manipulating the layout of a biomolecu-
lar interaction network up to tens of thousands of nodes
on a desktop computer, while providing several network
abstraction and comparison operators. The most recent
feature-rich network data analysis software tool, Biologi-
cal Networks [21], enables advanced bioinformatics users
to integrate microarray data analysis with biomolecular
interaction network analysis over a diverse set of database
choices through powerful template-based query inter-
faces. Pathway Studio [22], which is available commer-
cially, also uses powerful visualization engine and query
interfaces, and allows its users to manage and access data
stored in relational databases and to integrate biomolecu-
lar interaction data from its PubMed literature mining
engine with other sources. In summary, current develop-
ment trend is to equip users with extended ability to query
and interpret existing experimental data, particularly
those from "Omics" platforms, in the emerging context of
biomolecular interaction networks.
Recent research in network biology has expanded beyond
the study of protein-protein interactions or protein-DNA
interactions, therefore presenting new challenges and
opportunities for biological network visualization and
analysis software. These networks are more complex, with
heterogeneous types of biological entities spanning broad
range of scales from molecular (i.e., DNA, proteins,
metabolites), to super-molecular (i.e., gene ontology cat-
egories, protein complexes, pathways), to intercellular
(i.e., signaling between different cell types), to tissue and
physiological (i.e., individual disorder types) levels. For
example, Goh et al. explored all known associations of
disease phenotypes by representing disease phenotypes
instead of molecular entities as nodes in a network graph
[23]. They described two new types of biological net-
works, "disease interaction network" and "disease-gene
network", in which the former represented disease names
as nodes and disease associations at the molecular level
(sharing > 1 disease genes between associated diseases) as
edges, while the latter represented genes as nodes and
gene associations shared in a common disease (shared > 1
diseases between associated genes) as edges. To character-
ize the global relationships between protein targets and
all chemical drug compounds available today, Yildirim et
al. [24] built a drug-target association network represent-
ing all known drugs and their targets recorded in the
DrugBank database [25]. The network offered an intrigu-
ing view with "hot" drug intervention points (popular
drug targets) and multi-targeted drugs clearly displayed.
Analyzing the data in multi-scale biological networks is
inherently more challenging than that of biomolecular
interaction networks, primarily because the heterogene-BMC Bioinformatics 2008, 9(Suppl 9):S5 http://www.biomedcentral.com/1471-2105/9/S9/S5
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ous interacting biological entities may differ significantly
in size, quality, complexity and annotation requirements,
making it combinatorial more difficult to develop user
interfaces that preserve usability and robustness at the
same time. Few existing tools today can empower users to
perform "visual analytics"–to discover novel information
through visualization–for multi-scale biological net-
works.
To support multi-scale biological network visual analytics
studies, new software tools must meet three basic require-
ments. First, the bulk of data should be managed by
robust backend engines that support rich schemas such as
relational database management systems (e.g., Post-
greSQL, Oracle) or XML/RDF data stores (e. g, Jena,
Piazza). Flat files quickly become unsustainable beyond
one or two spreadsheets of custom user input data, due to
lack of a standard schema and difficulty in combining
information from separate spreadsheets. Second, iterative,
exploratory and bi-directional data analysis capabilities to
save temporary results and build visualization sessions on
top of one another should be a pre-requisite. Many cur-
rent software tools support only one-way information
flow from data sheets to visualization, and therefore
should be referred to as "visual annotation" or "visual dis-
play" tools instead of "visual analytic" tools. Third, visual
querying languages, even if borrowed directly from SQL in
relational database querying or SPARQL in semantic web
based data querying, will become quite beneficial to
advanced users, who have to filter different facets of bio-
logical networks and manipulate complex network analy-
sis tasks, by automating tasks that are "menu-driven" or
"mouse-click intensive". As Suderman et al recently sur-
veyed, none of the 35 commonly used biological network
visualization tools supported such query languages
embedded directly [26].
We developed ProteoLens as a new visual analytic soft-
ware platform for creating, annotating and analyzing
multi-scale biological networks. When compared with
existing biological network visualization tools, Proteo-
Lens introduced a new set of design choices, which made
it easy for bioinformatics expert data analysts work on
large sets of biological networks and Omics data. There
are three primary characteristics that distinguish it from
existing network visualization tools. First, it supports
direct database connectivity to Oracle and PostgreSQL
database and SQL statements including both Data Defini-
tion Languages (DDL) and Data Manipulation Languages
(DML). Users of ProteoLens can use the tool to iteratively
prepare data stored in relational databases without leav-
ing the visual analytic environment. Data from different
tables in a complex relational database schema can also be
queried on the fly to create networks at the appropriate
level for exploration. Second, ProteoLens supports graph/
network represented data expressed in standard Graph
Modeling Language (GML) formats. Therefore, visual lay-
outs performed in comparable software tools can interop-
erate with ProteoLens as long as they also support GML
standards. This allows users to perform visual network
analysis for data from heterogeneous sources that are syn-
tactically represented in non-relational format. Third, it
supports the decoupling of complex user interfaces for
network visualization into two separate functional layers:
data annotation and data visualization. The concepts of
"node association rules" and "edge association rules" pro-
vide users with significant flexibility in choosing what
data attributes (e.g., score, rank, description) to map to
nodes or edges, and association visualization display
options allow to select visual effects to represent values of
these attributes later.
In the next several sections, we first describe ProteoLens
implementation and then demonstrate how it can be used
to enable multi-scale biological network-based research
through three case studies.
Implementation
ProteoLens is a standalone software tool written in Java
programming language. Its software architecture consists
of two separate functional layers – a data processing layer
at the backend and a data visualization layer at the fron-
tend–connected by a network data association engine
(Figure 1). Different from conventional network visuali-
zation software, where data preparation prior to visualiza-
tions is usually not supported by the software itself, the
ProteoLens data processing layer allows network data to
be pre-processed and integrated using built-in database
management utilities. The data visualization layer at the
frontend enables users to iteratively build and layout
query-based (sub)networks and overlay them with visu-
ally displayed annotations as additional data sets are
brought in. The network data association engine bridges
the two functional layers by creating network data associ-
ation rules (to be described next) between pre-processed
data elements and identifiers of network nodes or edges.
This design enables users to navigate between data man-
agement and data visualization iteratively until useful
insights from the proper visualization are established.
Network data association rules: the concept
Network data association rules represent a basic concept
in ProteoLens design. A network data association rule
defines a relationship between a network data attribute
such as an edge or a node and other non-network data
attributes such as a computed score or an expression
value. Such an association rule establishes the mapping
between data in the data processing layer and data in the
data visualization layer. There are two types of association
rules:BMC Bioinformatics 2008, 9(Suppl 9):S5 http://www.biomedcentral.com/1471-2105/9/S9/S5
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1) Graph Node Association Rules. For example, Rule X: {Pro-
tein ID}  → {Protein Name}defines the network data
attribute "Protein ID" as an identifying attribute for a net-
work node further annotated with a node attribute "Pro-
tein Name". Note that the network attribute "Protein ID"
and associated non-network attribute "Protein Name"
may not necessarily be stored in the same database table
and may be defined using a complex SQL query for visual
data mapping purposes only.
2) Graph Edge Association Rules. For example, Rule X: {Pro-
tein ID A, Protein ID B} → {} defines the combination of
two network data attributes, "Protein ID A" and "Protein
ID B", as identifying attributes for a network edge without
further annotations; whereas Rule Y: {Protein ID A, Pro-
tein ID B} → {Interaction Score} defines the combination
of two network data attributes, "Protein ID A" and "Pro-
tein ID B", as identifying attributes for a network edge fur-
ther annotated with an edge attribute "Interaction Score".
Similar to graph node association rules, the network
attributes and non-network attributes may come from dif-
ferent physical data structures.
Data processing layer
The data processing layer is the place where biological
data from different sources, including flat files, XML data
and tabular data in relational databases, can be managed
and converted from one format into another for subse-
quent analysis. In ProteoLens, users could specify the
sources of data, pre-process data and make certain subsets
of data available to the subsequent data analysis. Unlike
conventional visualization software tools, ProteoLens
supports full Structured Query Language (SQL)–including
both Data Definition Languages (DDL) and Data Manip-
ulation languages (DML)–for these tasks. The combina-
tion of DDL and DML is particularly powerful for network
biological studies, since many network data association
rules may require selected data sets (via DML) and nested
definition of complex data structures (via DDL) by pull-
ing data from many physical table locations. In Proteo-
Lens, the data processing layer is implemented with the
combination of GML data handler and Oracle 11 g/Post-
greSQL relational database engines.
Data visualization layer
The data visualization layer is the place where specified
network data attributes and data association rules are con-
verted to network layouts and network visual properties.
The data visualization layer accepts network data associa-
tion rules, lays out the drawing of networks as graphs, and
visualizes network nodes and edges using graphical
attributes defined in the network data association rules. In
ProteoLens, the data visualization layer is implemented
with a fully functional graph editor, which supports laying
out the nodes and edges in the network and editing their
graphical attributes such as colors and shapes with rules
An overview of the ProteoLens core architecture Figure 1
An overview of the ProteoLens core architecture. The design of ProteoLens decoupled the data processing and visuali-
zation presenting in two layers and the two layers communicated by the abstract Data Associations. The major components of 
ProteoLens are SQL data retrieving engine, network layout engine and graph attributes editing engine.BMC Bioinformatics 2008, 9(Suppl 9):S5 http://www.biomedcentral.com/1471-2105/9/S9/S5
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defined in network data association rules. ProteoLens sup-
ports multiple independent network views. In a network
view, each associated attribute specified by the association
rule can be added either as a node attribute or an edge
attribute, depending on the association rule type. Any
numbers of associations can be selected as annotation
sources to modify the appearance of network nodes and
edges. In ProteoLens, the graph layout is extended from
yWorks Java package 3.0, a commercially available graph
layout library.
Results and discussion
New features
Figure 2 illustrates the core functionalities of ProteoLens.
We compared ProteoLens with several existing popular
visualization software tools, including Cytoscape, VisANT
and BiologicalNetworks, and summarized the compari-
son in Table 1. We describe the features of ProteoLens in
detail in this section.
a. Relational and XML data support
Currently, ProteoLens supports two types of physical data
sources: tab-delimited text files on the local file system
and tables/views in relational tables managed by Oracle
10 g or PostgreSQL 8.x database management systems. A
user can manage and query the data stored in the rela-
tional database, create network data association rules
from the view, and immediately make the rule available
for visual annotation. Since only meta-data are stored
when a data association is created, the query execution
can be performed in real time of visualization against the
underlying complex data structure in the database. This
design allows for an efficient data retrieval and analysis,
and saving of the data file and workspace resources.
Almost infinite configurations of data views can be cre-
ated from multiple underlying data sources, and be used
for building complex integrated visualizations. Proteo-
Lens also supports semi-structured data format in Graph
Modeling Language (GML) – the standard file format in
the Graphlet graph editor system, for non-relational
graphs. Network visualization is created in a view can be
saved in a GML file, thus allowing for reopening and fur-
ther editing in a new session, or data exchange without
relational databases. The network view can be exported as
a JPEG or PNG file. The user can import and manipulate
any network data using standard GML file formats in
addition to structured data stored in the relational data-
bases. ProteoLens stores every data association in a ses-
The overview core functionalities of ProteoLens Figure 2
The overview core functionalities of ProteoLens. Some of the core functionalities of ProteoLens labelled in this figure: 
a) ProteoLens can access both the relational database and local file system, b) the SQL statement can be edited and run in the 
software environment for data association building, c) SQL-like for building the sub network by retrieving particular characters 
of nodes/edges, d) convenient quick query of the nodes in the network view and sub-network retrieving, and e) flexible and 
comprehensive annotation adding.BMC Bioinformatics 2008, 9(Suppl 9):S5 http://www.biomedcentral.com/1471-2105/9/S9/S5
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sion configuration XML file. Users can save the session
and recommence their analysis at any time.
b. SQL-based visual data analysis
ProteoLens supports direct database connectivity through
Java Database Connectivity (JDBC) to Oracle and Post-
greSQL database tables and views, and the entire set of
database operations can be specified using full SQL state-
ments including Data Definition Languages (DDL) and
Data Manipulation languages (DML). This extends the
range of data that expert users may bring into later net-
work visualizations for annotation and visual exploration
tasks. Users of ProteoLens can iteratively prepare data
stored in relational databases without leaving the visual
analytic environment. Data from different tables in a
complex relational database schema can also be queried
on the fly to create networks at the appropriate level for
exploration. SQL queries are also used to present "views"
of different underlying database tables for network data
associations, therefore making it possible for users to per-
form all visualization pre-analysis without leaving the
ProteoLens platform.
c. Flexible network data visual annotation
In ProteoLens, users can explicitly define network data
association rules. As described earlier, the IDs of the nodes
in the network are used for attaching multiple attributes in
the rule for subsequent visual annotations. The annota-
tion of an edge is based on the mapping of attributes in
the rule identified by two interacting node IDs for each
edge. Graphical attributes currently available for auto-
matic node annotations are: label, size, shape, and fill
color. The latter annotation allows mapping multiple or
multiple-valued properties (multiple colors per node
object), in which case pie-chart style filling will be drawn.
Graphical attributes currently available for automatic
edge annotation are: line style, width, color, and text
label. There are two types of mappings between attributes
and visual properties: 1) the categorical mapping type that
allows displaying attributes with discrete set of specific
property values (for instance, using protein ID → GO
molecular function association rule, and requesting all
nodes annotated as a "kinase" or a "phosphatase" to be
colored in red); and 2) the continuous-range mapping type
that allows displaying properties with continuous numer-
Table 1: Compare ProteoLens against Cytoscape, VisANT and BiologicalNetworks.
ProteoLens Cytoscape VisANT BiologicalNetworks
Graph manipulation yFiles yFiles and GINY In house Cytoscape
Laying out Network 
Algorithm
force-directed, Radial 
Layout hierarchical, 
circular, orthogonal
More than 13 kinds of 
layout styles.
force-directed grid, circular, force-
directed
Drawing appearance node shape/colour/border/
label, edge colour/style/
direction/label
node shape/colour/border/
label, edge colour/style/
direction/label
node shape/colour/size node shape/colour/border/
label, edge colour/style/
direction/label
Filters select nodes/links 
according to properties or 
using SQL statement for 
table attributes selecting 
directly
select nodes/links 
according to properties 
(SQL-like)
Several 'select' filters 
available
select nodes/links 
according to properties 
(SQL-like)
Expand/Collapse nodes expand node neighbours Plug-in expand node neighbours
Database Incline Common Relational 
database
Plug-in Predictome PathSys
System Requirements Java stand-alone Java applet or stand-alone Java applet JSP (Java Server Pages)
Save GML,XML session GML,SIF network with layout save all work as projects
Imports Text, GML, XML, Oracle 
or PostgreSQL
text, GML, expression 
matrix, OBO
PSI-MI, BioPAX, KGML, 
network relations (text)
microarray data 
(Stanford,Affymetrix,TIGR,
GenePix), SBML, SIF, PSI-
MI, BioPAX
Exports JPEG,BMP, GML network 
relations, Node lists, 
selections node lists (text)
graphical file, SVG, GML, 
network relations (text)
PSI-MI, BioPAX, SVG, 
JPEG, network relations 
(text)
GIF, JPEG, SWF, PDF, 
PNG, PostScript, RAW, 
SVG, BMP
Comments & other 
features
Embedding the SQL query 
make its software more 
flexible to suit powerful 
bioinformatics experts 
usage
The importance of 
Cytoscape is its solid 
support for plug-in, 
growing number of which 
is available.
Statistics ability for 
topological characteristic 
analysis and integrating 
several biological database
Integrated visualization and 
analysis of expression data.
*A summary of attributes of Cytoscape, VisANT and BiologicalNetworks as presented in detail by Matthew Suderman et al in review. [26]BMC Bioinformatics 2008, 9(Suppl 9):S5 http://www.biomedcentral.com/1471-2105/9/S9/S5
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ical values (e.g. expression levels, or interaction confi-
dence scores), using color gradients, shape sizes or line
widths.
The use of declarative SQL to specify how data should be
managed, pre-processed, associated, and then subse-
quently mapped to visual properties is characteristic of
ProteoLens. A user can use SQL queries to specify and
store "associations" between nodes/edges and other
attributes. These associations can be used to visually
annotate large displayed networks using node/edge
shape, size, weight, color and text. This gives users more
choices and flexibility than any custom-built annotation
user interface for complex visual network analysis.
d. Sub-network manipulations
Users of ProteoLens can conveniently specify sub-net-
works based on existing networks to conduct studies in a
specific biological context. Users could specify what types
of nodes or edges to include in the sub-network according
to set of qualifying conditions. For example, a user may
retrieve all the interactions where at least one of the part-
ners is annotated as "cell-cycle related" proteins. This does
not require bringing into the view a huge biomolecular
network in its entirety and then filtering/zooming in onto
its part. Neither this specification requires users to prepare
the data outside the ProteoLens visualization software
platform; instead, users could write a SQL statement to
first create a relational view between protein nodes and
gene ontology annotations and then to create a new net-
work data association of "nodes", with which a new sub-
network could be retrieved from the original network and
annotated. This approach can be imagined as a huge
underlying biomolecular network stored in the backend
databases and/or files and integrated (logically) by the vir-
tue of data associations. Only the relevant part of the net-
work is physically pulled into the visualization layer for
detailed examination. Such visualized sub-networks are
not "final" either but could be gradually updated by itera-
tively using additional queries to bring more data from
different sources into the view, until the final complex
network is built. In comparison, Cytoscape does not sup-
port a network filtering feature and requires the entire net-
work for visual data analysis to be pre-formatted properly
and imported from the input data files. A Cytoscape soft-
ware plug-in, Bubble Router, has became available
recently; however, it allows only creating a sub-network
with one-pass filters, which cannot be iteratively extended
to fit the exploratory nature of visual analytic operations.
Case studies
To demonstrate the new functionalities of ProteoLens, we
show several case studies that demonstrate how the soft-
ware is used to solve real-world biological problems.
Case study 1: human cancer association network
Decade-long study of disease-causing genes has generated
a comprehensive set of "disease disorders – genes" rela-
tionship pairs (also referred to as the "diseasome"), which
are represented in the OMIM morbidity map [27]. Goh et
al. recently showed a global view of the "human disease
network" (HDN), which included 22 disease disorder
classes, 1284 disease disorders, and 1777 disease genes
[23]. In the HDN, nodes represented disease disorders,
while edges represented the presence of at least one com-
mon gene between two connected disease disorders. The
study of HDN showed how diseases related to one
another and formed major disease clusters connected by
underlying shared molecular entities. The initial construc-
tion of the network for HDN, however, was labor-inten-
sive, since preparation of the disease-gene association file
and other gene/disease annotation files needed to be
processed separately with different software tools before
visualizations were to be performed.
In this case study, we show how to reproduce a similar
human disease network with ProteoLens, using data for
13 common types of cancers derived from the OMIM
database, papers by Goh et al, and public biological data-
bases [23,27]. The visual analytic process can be divided
into four steps, network data pre-processing, network data
association rule specifications, initial network visualiza-
tion, and iterative visual data analysis, all without leaving
the software platform:
Network data pre-processing
At the beginning of the analysis, only one database table–
the GENE_DISEASE_MAP table–is available. The table
contains the pairing relationships between disease disor-
ders and genes. From this table, we could define the rela-
tionship of two individual diseases as "associated" if and
only they shared at least one common gene implicated in
SQL statement for identifying disease-disease association Figure 3
SQL statement for identifying disease-disease associ-
ation. The SQL statement created a view recording the rela-
tionship of two individual diseases as "associated" if they 
shared at least one common disorder gene.BMC Bioinformatics 2008, 9(Suppl 9):S5 http://www.biomedcentral.com/1471-2105/9/S9/S5
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both diseases. The SQL to create such a specification is
quite straightforward: (Figure 3)
The constructed view put together three attributes. The
first and second attributes represent paired cancer diseases
that share at least one common disorder gene. The third
attribute represent the total count of shared genes
between the shared diseases. To create an annotation for
cancers and total count of genes implicated in each cancer,
we can write the following SQL statements inside Proteo-
Lens: (Figure 4)
Network data association rule specifications
Here, we assign visual attributes of interest to either net-
work nodes or edges, using network data association
rules. In this case study, we can create the following sam-
ple association rules using ProteoLens:
￿ Disease_gene_implicated: {Disease_Name} →
 {Cnt_Gene}
￿ D2D_gene_shared: {Disease_A, Disease_B} →
 {Cnt_Gene_Shared}
Note that network data association rules must involve
mapping from either the node (identified by
Disease_Name) or edge (identified by Disease_A,
Disease_B) to an annotation attribute such as "Cnt_Gene"
or "Cnt_Gene_Shared". The former data association rule
is "node-styled" and the latter data association rule is
"edge-styled", since they provide annotations (attributes)
for nodes and edges, respectively.
Initial network visualization
The final construction of the human cancer association
network in ProteoLens is now simplified. First, we lay out
the basic network disease pairing information from
"D2D_INTERACTION"; then, we apply all the node-style
network data association rules to the annotation of
"nodes" and all the edge-style network data association
rules to the annotation of "edges". In this case study, we
chose to represent the total numbers of genes implicated
in a given disease as sizes of the disease nodes, and the
total numbers of genes shared between two diseases as the
edge widths.
Iterative visual data analysis
ProteoLens supports iterative visual analysis by allowing
additional visual information to be captured as network
nodes/edges annotations later. In this case study, after
examining that breast cancer is well studied (with many
mapped genes) and lung cancer is not, we decided to fur-
ther incorporate first-time incident frequency during 2007
in the U.S., by retrieving relevant statistics from the Amer-
ican Cancer Society [28] and annotating disease names
represented as network nodes with color gradients from
white to red. The final view of the annotated network is
shown in Figure 5. The figure reveals intriguing insights
into the relations of the human cancers to each other.
Interestingly, lung cancer studies are found to be under-
represented for all cancers, given its large number of new
incident rates; the discovery opportunities for lung cancer
seem huge.
Case study 2: compound-target interaction network
Different from conventional network biology studies or
case study #1, this case study is concerned with two differ-
ent types of biological entities–chemical compounds and
drug target proteins. We attempt to understand the specif-
icity of drug compound actions and to visualize potential
drug targets for major diseases.
Using ProteoLens, we created drug-target network visuali-
zation, using hierarchical layout and two different node
shapes to represent drugs and protein targets separately.
In Figure 4A, we show a snapshot of the network, which
contains all the drug compounds developed for
ACM2_HUMAN and its direct interacting protein part-
ners. ACM2_HUMAN is an acetylcholine binding receptor
and a member of the G-protein-coupled receptors (GPCR)
protein family–a major class of current drug targets that
accounts for more than 50% of known contemporary
drug compounds [29].
The entire protein-drug interaction data was downloaded
from DrugBank [25] and stored in Oracle 10 g database
tables. It is interesting to note that target proteins could be
visually clustered, and the clustering relationships corre-
late well with the evolutionary relationship defined by
separate alignments of protein sequences (see Figure 4B).
While a few ACM2_HUMAN interacting proteins such as
SC6A1_HUMAN, SC6A2_HUMAN and ACHA2_HUMAN
are not members of GPCRs, all other proteins belonged to
GPCRs. ACM1_HUMAN to ACM5_HUMAN are acetyl-
choline receptors. As shown in Figure 6, the results suggest
that proteins with similar phylogenetic profiles tend to
share similar core set of drug compounds, perhaps due to
SQL statement for counting the genes involving in every dis- ease Figure 4
SQL statement for counting the genes involving in every dis-
ease.BMC Bioinformatics 2008, 9(Suppl 9):S5 http://www.biomedcentral.com/1471-2105/9/S9/S5
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similarities of underlying protein structures in the proxim-
ity of the functional site. The visualization of such drug-
target network opens up new "network pharmacology"
study opportunities, in which a drug may be evaluated for
its ability to find multiple "targets" related to a specific
biological sub-network [30]; while the effects of drug
compounds may also be evaluated in the context of com-
mon structures of all interacting target proteins. This type
of visual network studies could help users develop novel
perspectives for drug designs and/or protein target valida-
tions.
Case study 3: peptide-protein mapping networks
In this case study, we apply ProteoLens to the study of
mass spectrometry (MS) based proteomics. In each tan-
dem mass-spectrometry experiment, many partially
Trypsin-digested peptides can be detected by the MS/MS
spectrometers and identified by MS analysis software. The
software normally aims to identify all the peptides from
MS spectra and to map them unambiguously to proteins
in the sample. Traditional MS analysis software identifies
proteins from peptides by directly mapping them to the
most common protein isoforms found in the pre-com-
puted MS search database; therefore, incomplete results
may arise, especially in cases where common peptides
may be shared by two or more protein isoforms.
In Figure 7, we show how ProteoLens could be used to
help establish all the relationships between found pep-
tides and possible protein isoforms that they may link to,
in the HIP2 database–an online database that collects all
experimentally identified proteins and peptide-mapping
evidence in normal human plasma[31]. Two proteins,
A1AG1_HUMAN and A1AG2_HUMAN, are shown in the
visualization network. By writing SQL inside ProteoLens,
we identify all the potential protein-peptide relationships:
(Figure 8).
In the peptide-protein mapping network shown, the com-
mon peptides identified and mapped to either protein in
the original experiments are colored green, whereas newly
mapped peptides are colored yellow. We also used differ-
ent node shapes to annotate peptides identified from dif-
ferent MS instrument types, e.g., IMS-MS instruments, LC-
MS/MS instruments or MALDI-MS instruments. By visual-
izing the raw data in the protein-peptide network, we can
see that both protein isoforms are found in human
plasma, since both common peptides and protein-specific
Disease-disease association network Figure 5
Disease-disease association network. This is a sub network of the cancer disease association network, built by retrieving 
13 kinds of popular cancer. In this representation, the node is a kind of cancer, and if two kinds of cancer have common genetic 
disorder genes, there is an edge connecting them. The size of nodes indicates the number of cancerogenic disorder genes and 
the color of nodes indicates the number of cases in 2007 in the U.S; dark red indicates more cases, light red indicates less 
number, and white indicates less statistic data. The width of edge indicates the number of common genetic disorder genes of 
two kinds of cancer disease.BMC Bioinformatics 2008, 9(Suppl 9):S5 http://www.biomedcentral.com/1471-2105/9/S9/S5
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peptides are found and mapped. Interestingly, IMS-MS
instruments are seen to resolve only one protein isoform
"A1AG1_HUMAN", suggesting that either the platform
could be biased towards identifying certain types of pep-
tides or the search database used for this experiment
might have not contained A1AG2_HUMAN. ProteoLens
Compound- protein target interaction network Figure 6
Compound- protein target interaction network. a) The compound-protein target interaction network is drawn by the 
ProteoLens hierarchical layout. b) The evolutionary tree of all the target proteins is drawn by ClustalW2 http://www.ebi.ac.uk/
Tools/clustalw2/index.html. For every protein sub family marked with a color, the node color in A corresponds to the color 
bar in B.BMC Bioinformatics 2008, 9(Suppl 9):S5 http://www.biomedcentral.com/1471-2105/9/S9/S5
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makes it easy for users to explore different hypothesis and
continue scientific explorations through iterative network
visual data analysis.
Conclusion
We developed ProteoLens as a multi-scale network visual
analytic software tool for advanced network biology stud-
ies. It is built on robust software architecture that supports
flexible network data association specification using rules,
integrates data processing through relational databases
and GML data files, and scalable data visualization
through layered annotations. It is intended for advanced
bioinformatics users who manage large existing sets of
biological data in the Oracle or PostgreSQL databases,
and who are skilled in SQL programming. ProteoLens is
by far the first bio-molecular network visualization soft-
ware with full SQL support. ProteoLens enables iterative
visual layout, annotation and exploration of bio-molecu-
lar networks. It effectively liberates advanced data analysts
from the burden of data preparation and processing prior
to generating visualization, and thus helps to better con-
centrate on the scientific visualization itself. The support
for both "network browsing" and "network querying"
operations makes ProteoLens a promising visual data ana-
lytic and visual data mining tool for hypothesis-driven
network biology studies. With future releases of Proteo-
Lens, we plan to add open Application Program Interfaces
(APIs) so that 1) Proteolens can interoperate with other
software tools in bioinformatics, and 2) third-party plug-
ins could be developed to accommodate expanding user
community needs.
Availability and requirements
Project name: ProteoLens
MS proteomic peptide-protein mapping network Figure 7
MS proteomic peptide-protein mapping network. The blue color marking nodes are the original common peptides of 
the two proteins, and the yellow ones are newly discovered common peptides. The peptides' nodes are marked in three kinds 
of shape indicating different MS experimental platforms.
SQL statement for identifying the protein-peptide relation- ship Figure 8
SQL statement for identifying the protein-peptide relation-
ship.BMC Bioinformatics 2008, 9(Suppl 9):S5 http://www.biomedcentral.com/1471-2105/9/S9/S5
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￿ Project home page: http://bio.informatics.iupui.edu/
proteolens/
￿ Operating system(s): The software is platform inde-
pendent and can run anywhere Java Virtual Machine runt-
ime is available. An installer is provided for Windows NT/
XP/2003/Vista users.
￿ Programming language: Java
￿ Other requirements: Java Runtime Environment (JRE)
version 1.5 or above is required.
￿ License: free software license to all users.
￿ Any restrictions to use by non-academics: Non-aca-
demic users can freely use the software for research pur-
poses. Non-academic users cannot redistribute, modify,
reverse-engineer, or resell the software for commercial
purposes.
List of abbreviations used
GINY- Graph Interface library; SQL -Structural query lan-
guage; PSI-MI – Proteomics Standards Initiative – Molec-
ular Interactions.
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